BMS will pay an upfront cost of $1.5bn, as well as $2bn in non-contingent anniversary payments through 2028. In addition, BioNTech will be eligible to receive up to $7.6bn in development ...

However many shareholders have stakes in both Celgene and BMS, meaning that they stand to face less risk from the deal. Investors will get to vote on the acquisition in a special meeting scheduled ...

BRISTOL, Tenn. (WJHL) – With the conclusion of Sunday’s Food City 500, there will be no more NASCAR in The Last Great Coliseum until September. In between now and then, however, BMS wil… ...

Claroty, the cyber-physical systems (CPS) protection company, today announced new research on the riskiest exposures among building management systems (BMS) and building automation systems (BAS). The ...

BMS saw grade 3 or 4 treatment-emergent adverse events in 11 of the 15 patients in the safety data set. Neutropenia, meaning low levels of a type of white blood cell, was the most common grade 3 ...

BMS: In literal terms, BMS stands for Broke My Scale. But it has nothing to do with weight. It’s a way of saying something is so good (pretty, ... Its social media meaning, ...

Aficamten uses the same mechanism of action as Camzyos, meaning that there’s a chance BMS’ failure in the disease could “read through to the class,” William Blair analysts noted.

BMS and BioNTech will jointly develop and commercialise the asset that targets both PD-L1 and VEGF-A. ... will mean BMS and BioNTech jointly share development and manufacturing costs on a 50:50 ...

Bristol-Myers Squibb’s (BMS) largest shareholder has come out against the company’s planned merger with Celgene, putting the future of the deal in doubt. The $74 billion deal, ...